Pfizer’s Setback And Emerging Breakthroughs

The European Medicines Agency has once again recommended to prolong the marketing suspension of Oxbryta (Voxelotor), a drug that treats sickle cell disease (SCD). The Pfizer therapy was first suspended last year, when emerging data from clinical…